🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of a study drug called PARP...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2018-08-10
Trial ID
NCT03631017
Treatments Being Tested
Neuroendocrine tumours (NETs) are generally slow growing, but some can be a...
Status
Completed
Location
BC Cancer
Start Date
2020-06-09
Trial ID
NCT04207762
Treatments Being Tested
The purpose of the OSS study is to evaluate a procedure involving a single ...
Status
Completed
Location
Service de Médecine Nucléaire - CHRU de Nancy-Brabois
Start Date
2020-02-04
Trial ID
NCT04157166
Quantitative parameters obtained with dynamic whole body imaging using posi...
Status
Unknown
Location
BC Cancer
Start Date
2019-11-01
Trial ID
NCT04017104
Treatments Being Tested
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for gastric o...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-10-20
Trial ID
NCT06646783
Treatments Being Tested
The aim of this study is to evaluate the diagnostic performance of Al18F-NO...
Status
Completed
Location
Universitaire Ziekenhuizen Leuven
Start Date
2020-10-07
Trial ID
NCT04552847
Treatments Being Tested
The primary objective of this study is to compare the 3-year overall surviv...
Status
Recruiting
Location
Tergooi MC
Start Date
2024-03-19
Trial ID
NCT06082492
Treatments Being Tested
MIGAT will develop and transfer software tools to assist ablation therapy o...
Status
Completed
Location
Hôpital cardiologique du Haut-Lévêque
Start Date
2014-09-01
Trial ID
NCT02275104
Extrinsic prewarming of iodinated CT contrast media (CM) to body temperatur...
Status
Unknown
Location
Chongqing Emergency Mediacl Centre
Start Date
2022-02-01
Trial ID
NCT05489055
Treatments Being Tested
This is a prospective, multicenter, self-controlled phase 3 clinical trial ...
Status
Completed
Location
Peking University Cancer Hospital & Institute
Start Date
2019-10-12
Trial ID
NCT04233476
Treatments Being Tested